Form 4: IGM Biosciences Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Lisa Lynn Decker, Chief Business Officer of IGM Biosciences, sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Lisa Lynn Decker, the Chief Business Officer of IGM Biosciences, sold 4,512 shares of common stock on March 14, 2025.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $1.23, with individual trades ranging from $1.19 to $1.28.
- Following the transaction, Decker directly owns 73,529 shares of IGM Biosciences common stock.
Sentiment
Score: 5
Explanation: This is a neutral transaction. An executive sold shares to cover taxes, which is a common practice and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
Form 4 filings are a routine part of the US stock market, and are required by the SEC to ensure transparency when company insiders trade their own company's stock. This filing indicates that an executive sold shares, which is not necessarily indicative of the company's performance or future prospects.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of the stock sale transaction. |
| 03/18/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.